Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FZQZ Oral Liquid in Ischemic Nephropathy
NCT02044835Phase 3Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- Jan 2013
- Primary completion
- Sep 2015
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of Fu-Zheng-Qu-Zhuo in ischemic nephropathy, atherosclerotic renal artery stenosis (ARAS), sponsored by Guang'anmen Hospital. Status: unknown.
02
Drugs
Fu-Zheng-Qu-Zhuo
03
Conditions
ischemic nephropathyatherosclerotic renal artery stenosis (ARAS)
Beyond the preview
Go deeper on NCT02044835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044835.